EXACT Sciences
EXASExact Sciences Corp. is a molecular diagnostics company with an initial focus on the early detection and prevention of colorectal cancer. Exact Sciences Corp. launched Cologuard in 2014, the first stool DNA test for colorectal cancer. The company was founded in 1995 in Marlborough, Massachusetts, bu …
© Wikipedia /
Creative Commons CC-BY-SA 3.0 more at Wikipedia
Insider trades and stock quote 2022-2024
All insider trades at EXACT Sciences
Subscribe RSSDate | Type | Insider | Position | Ø-Price | Volume |
---|---|---|---|---|---|
5/1/2024 | Sell | Elliott, Jeffrey Thomas | Chief Financial Officer | $60.2 | $8,180 |
5/1/2024 | Sell | Condella, Sarah | EVP, Human Resources | $60.2 | $6,135 |
5/1/2024 | Sell | Baranick, Brian | EVP, GM., Precision Oncology | $60.2 | $6,617 |
5/1/2024 | Sell | Orville, Jacob A. | General Manager, Screening | $60.2 | $6,135 |
5/1/2024 | Sell | Conroy, Kevin T. | President and CEO | $60.2 | $69,473 |